Related Experiment Video
Updated: Jun 13, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction
Arevik Mosoian1, Avelino Teixeira, Colin S Burns
1Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. arevik.mosoian@mssm.edu
Prothymosin-alpha (ProTalpha), a CD8+ T cell protein, activates Toll-like receptor 4 (TLR4) to induce type I interferons (IFN). This innate immune response potently suppresses HIV-1, offering new therapeutic strategies for viral infections.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Type I interferons (IFN) are crucial for innate immunity against pathogens via Toll-like receptor (TLR)-dependent and -independent pathways.
- Prothymosin-alpha (ProTalpha), a protein from CD8+ T cells, inhibits HIV-1, but its mechanism of action was unclear.
Purpose of the Study:
- To elucidate the mechanism by which ProTalpha exerts its antiviral activity against HIV-1.
- To investigate the role of TLR4 in ProTalpha-mediated immune responses.
Main Methods:
- Stimulation of cells with native and recombinant ProTalpha.
- Assays to measure type I IFN production.
- HIV-1 inhibition assays in the presence and absence of TLR4.
- Analysis of ProTalpha peptide activity.
Main Results:
- Exogenous ProTalpha functions as a ligand for TLR4, stimulating type I IFN production.
- ProTalpha potently suppresses HIV-1 replication post-entry.
- ProTalpha's antiviral activity is dependent on TLR4 and retained by an acidic peptide fragment.
- ProTalpha contributes to the previously observed CD8+ cell-mediated inhibition of HIV-1.
Conclusions:
- ProTalpha bridges adaptive immunity (CD8+ T cells) and innate immunity (TLR4-mediated IFN production) to suppress HIV-1.
- The mechanism of IFN induction by ProTalpha presents potential therapeutic avenues for IFN-sensitive viruses.
More Related Videos
08:11Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.
Published on: September 1, 2015
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
TGF - β Signaling Pathway
Sexually Transmitted Infections